Abstract
Peroxisome Proliferator-Activated Receptor γ (PPARγ) full agonists are molecules with powerful insulin-sensitizing action that are used as antidiabetic drugs. Unfortunately, these compounds also present various side effects. Recent results suggest that effective PPARγ agonists should show a low transactivation activity but a high binding affinity to inhibit phosphorylation at Ser273. We use several structure activity relationship studies of synthetic PPARγ agonists to explore the different binding features of full and partial PPARγ agonists with the aim of differentiating the features needed for binding and those needed for the transactivation activity of PPARγ. Our results suggest that effective partial agonists should have a hydrophobic moiety and an acceptor site with an appropriate conformation to interact with arm II and establish a hydrogen bond with Ser342 or an equivalent residue at arm III. Despite the fact that interactions with arm I increase the binding affinity, this region should be avoided in order to not increase the transactivation activity of potential PPARγ partial agonists.
Similar content being viewed by others
Abbreviations
- LBD:
-
Ligand binding domain
- PPAR:
-
Peroxisome proliferator-activated receptor
- QSAR:
-
Quantitative structure–activity relationship
- SAR:
-
Structure activity relationship
- TZDs:
-
Thiazolidinediones
References
Berger J, Moller DE (2002) Annu Rev Med 53:409
Willson TM, Lambert MH, Kliewer SA (2001) Annu Rev Biochem 70:341
Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) J Biol Chem 270:12953
Feldman PL, Lambert MH, Henke BR (2008) Curr Top Med Chem 8:728
Pourcet B, Fruchart J, Staels B, Glineur C (2006) Expert Opin Emerg Drugs 11:379
Jones D (2010) Nat Rev Drug Discov 9:668
Gelman L, Feige JN, Desvergne B (2007) Biochim Biophys Acta 1771:1094
Grether U, Klaus W, Kuhn B, Maerki HP, Mohr P, Wright MB (2010) ChemMedChem 5:1973
Farce A, Renault N, Chavatte P (2009) Curr Med Chem 16:1768
Zoete V, Grosdidier A, Michielin O (2007) Biochim Biophys Acta 1771:915
Pochetti G, Godio C, Mitro N, Caruso D, Galmozzi A, Scurati S, Loiodice F, Fracchiolla G, Tortorella P, Laghezza A, Lavecchia A, Novellino E, Mazza F, Crestani M (2007) J Biol Chem 282:17314
Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, Nettles KW, Griffin PR (2007) Structure 15:1258
Montanari R, Saccoccia F, Scotti E, Crestani M, Godio C, Gilardi F, Loiodice F, Fracchiolla G, Laghezza A, Tortorella P, Lavecchia A, Novellino E, Mazza F, Aschi M, Pochetti G (2008) J Med Chem 51:7768
Lu I, Huang C, Peng Y, Lin Y, Hsieh H, Chen C, Lien T, Lee H, Mahindroo N, Prakash E, Yueh A, Chen H, Goparaju CMV, Chen X, Liao C, Chao Y, Hsu JT, Wu S (2006) J Med Chem 49:2703
Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR, Spiegelman BM (2010) Nature 466:451
Houtkooper RH, Auwerx J (2010) Nature 466:443
Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM (1996) J Med Chem 39:665
Dropinski JF, Akiyama T, Einstein M, Habulihaz B, Doebber T, Berger JP, Meinke PT, Shi GQ (2005) Bioorg Med Chem Lett 15:5035
Liu W, Liu K, Wood HB, McCann ME, Doebber TW, Chang CH, Akiyama TE, Einstein M, Berger JP, Meinke PT (2009) J Med Chem 52:4443
Acton JJ, Black RM, Jones AB, Moller DE, Colwell L, Doebber TW, Macnaul KL, Berger J, Wood HB (2005) Bioorg Med Chem Lett 15:357
Liu K, Black RM, Acton JJ, Mosley R, Debenham S, Abola R, Yang M, Tschirret-Guth R, Colwell L, Liu C, Wu M, Wang CF, MacNaul KL, McCann ME, Moller DE, Berger JP, Meinke PT, Jones AB, Wood HB (2005) Bioorg Med Chem Lett 15:2437
Debenham SD, Chan A, Lau FW, Liu W, Wood HB, Lemme K, Colwell L, Habulihaz B, Akiyama TE, Einstein M, Doebber TW, Sharma N, Wang CF, Wu M, Berger JP, Meinke PT (2008) Bioorg Med Chem Lett 18:4798
Thor M, Beierlein K, Dykes G, Gustavsson AL, Heidrich J, Jendeberg L, Lindqvist B, Pegurier C, Roussel P, Slater M, Svensson S, Sydow-Bäckman M, Thornström U, Uppenberg J (2002) Bioorg Med Chem Lett 12:3565
Hopkins CR, O’neil SV, Laufersweiler MC, Wang Y, Pokross M, Mekel M, Evdokimov A, Walter R, Kontoyianni M, Petrey ME, Sabatakos G, Roesgen JT, Richardson E, Demuth TP (2006) Bioorg Med Chem Lett 16:5659
Lamotte Y, Martres P, Faucher N, Laroze A, Grillot D, Ancellin N, Saintillan Y, Beneton V, Gampe RT (2010) Bioorg Med Chem Lett 20:1399
Goebel M, Clemenz M, Staels B, Unger T, Kintscher U, Gust R (2009) ChemMedChem 4:445
Goebel M, Staels B, Unger T, Kintscher U, Gust R (2009) ChemMedChem 4:1136
Seto S, Okada K, Kiyota K, Isogai S, Iwago M, Shinozaki T, Kitamura Y, Kohno Y, Murakami K (2010) J Med Chem 53:5012
Furukawa A, Arita T, Satoh S, Wakabayashi K, Hayashi S, Matsui Y, Araki K, Kuroha M, Ohsumi J (2010) Bioorg Med Chem Lett 20:2095
Garcia-Vallvé S, Palau J, Romeu A (1999) Mol Biol Evol 16:1125
Salam NK, Nuti R, Sherman W (2009) J Chem Inf Model 49:2356
Wolber G, Langer T (2005) J Chem Inf Model 45:160
Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) J Comput Aided Mol Des 20:647
Giaginis C, Theocharis S, Tsantili-Kakoulidou A (2009) Mini Rev Med Chem 9:1075
Acknowledgments
This manuscript was edited for English language fluency by American Journal Experts. This study was supported by Grant Number AGL2008-00387/ALI from the Ministerio de Educación y Ciencia of the Spanish Government and the ACC1Ó (TECCT10-1-0008) program (Generalitat de Catalunya). The authors wish to thank the Servei de Disseny de Fàrmacs (Drug Design Service) of the Catalonia Supercomputer Center (CESCA) for providing access to Schrödinger software.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Guasch, L., Sala, E., Valls, C. et al. Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity. J Comput Aided Mol Des 25, 717–728 (2011). https://doi.org/10.1007/s10822-011-9446-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-011-9446-9